ba0005p111 | Cancer and bone: basic, translational and clinical | ECTS2016
Kyrgidis Athanassios
, Yavropoulou Maria
, Lagoudaki Rosa
, Andreadou Anna
, Andreadis Charalambos
, Yovos John
, Kouvelas Dimitrios
: Osteonecrosis of the jaws (ONJ) is a relatively new adverse effect associated with bisphosphonate therapy, but no causal association has been established. By definition, a patient is considered to suffer from ONJ if he has current or previous treatment with a bisphosphonate, exposed bone in the maxillofacial region that has persisted for more than 8 weeks and no history of radiation therapy to the jaws. It has been proposed that ONJ could be linked with impaired topical immu...